2008
Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City
Amesty S, Ompad D, Galea S, Fuller C, Wu Y, Koblin B, Vlahov D. Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City. Journal Of Community Health 2008, 33: 139-148. PMID: 18185987, DOI: 10.1007/s10900-007-9082-4.Peer-Reviewed Original ResearchConceptsEvidence of infectionHBV vaccinationPrevious vaccinationSerological evidenceHepatitis B vaccination coveragePrevious hepatitis B vaccinationPrevious HBV infectionPrevious HBV vaccinationHepatitis B vaccinationHepatitis B vaccineHigh-risk groupYears of ageCommunity-based sampleB vaccinationHBV infectionB vaccineVaccination statusVaccination coverageRisk groupsHigh school educationVaccinationSusceptible individualsDrug usersInfection rateBivariate analysis
2001
Factors Associated with Adolescent Initiation of Injection Drug Use
Fuller C, Vlahov D, Arria A, Ompad D, Garfein R, Strathdee S. Factors Associated with Adolescent Initiation of Injection Drug Use. Public Health Reports 2001, 116: 136-145. PMID: 11889281, PMCID: PMC1913680, DOI: 10.1093/phr/116.s1.136.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdolescent BehaviorAdultAge FactorsBaltimoreBlack or African AmericanCommunity-Institutional RelationsFemaleHealth BehaviorHepatitis CHIV InfectionsHumansLogistic ModelsMalePrimary PreventionProspective StudiesRisk AssessmentRisk-TakingSexual BehaviorSubstance Abuse, IntravenousConceptsInjection drug useDrug useMedian ageInitiation of injectionCrack smokingNon-injection drug useAdolescent initiationHigh-risk groupYears of ageIllicit drug useAfrican AmericansDrug use practicesStudy enrollmentPrevents onsetEarly prevention effortsDrug usersMultivariate analysisCocaine useCondom useSmoking marijuanaLogistic regressionYoung drug usersPrevention effortsYoung adulthoodSmoking
1997
Seroreactivity to hepatitis E virus in areas where the disease is not endemic
Thomas D, Yarbough P, Vlahov D, Tsarev S, Nelson K, Saah A, Purcell R. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. Journal Of Clinical Microbiology 1997, 35: 1244-1247. PMID: 9114415, PMCID: PMC232737, DOI: 10.1128/jcm.35.5.1244-1247.1997.Peer-Reviewed Original ResearchConceptsInjection drug usersHistory of hepatitisVirus antibodiesBlood donorsHigh-risk drug-using practicesHomosexual menHepatitis E virus antibodiesHepatitis E diseaseC virus antibodyHepatitis C antibodyHigh-risk groupHigh-risk populationHigh-risk sexual practicesDrug use practicesHepatitis AE virusC antibodySubclinical infectionB antibodiesE diseaseDrug usersEnzyme immunoassaySerum samplesHomosexual malesInfection
1992
HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects.
Selnes O, McArthur J, Royal W, Updike M, Nance-Sproson T, Concha M, Gordon B, Solomon L, Vlahov D. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992, 42: 1924-30. PMID: 1407574, DOI: 10.1212/wnl.42.10.1924.Peer-Reviewed Original ResearchConceptsIntravenous drug usersIntravenous drug useDrug usersHIV infectionSerostatus groupsHIV-seropositive intravenous drug usersDrug useHIV-1 infectionHigh-risk groupRoute of acquisitionLongitudinal neuropsychological evaluationCross-sectional comparisonPreexisting deficitAsymptomatic subjectsLongitudinal followAdditional cognitive impairmentPresymptomatic stageNeurocognitive abnormalitiesCognitive impairmentNeuropsychological evaluationNeuropsychological deficitsSame cohortBisexual menInfectionSignificant differences